Abbonarsi

The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarction - 17/12/18

Doi : 10.1016/j.ahj.2018.07.017 
Sonya N. Burgess, MBChB, BSc a, b, c, 1, John K. French, MBChB, PhD a, b, , Tuan L. Nguyen, MBBS, PhD a, b, Melissa Leung, MBBS, BSc(Med), MBiostat, PhD a, b, David A.B. Richards, MBBS, MD a, b, Liza Thomas, MBBS, PhD a, b, d, Christian Mussap, MBBS, PhD a, b, Sidney Lo, MBBS a, b, Craig P. Juergens, MBBS, DMedSc a, b
a Department of Cardiology, Liverpool Hospital, Sydney, New South Wales, Australia 
b The University of New South Wales, Sydney, New South Wales, Australia 
c Department of Cardiology, Nepean Hospital, Sydney, New South Wales, Australia 
d Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia 

Reprint requests: Professor John K French, MBChB, PhD, Department of Cardiology, Liverpool Hospital, Elizabeth St, Liverpool, New South Wales 2170, Australia.Department of CardiologyLiverpool HospitalElizabeth StLiverpoolNew South Wales2170Australia

Abstract

Background

In ST-elevation myocardial infarction (STEMI) in patients with multivessel disease, there is a lack of consensus regarding the importance of complete revascularization and the timing of treatment of nonculprit stenoses. Our objective was to investigate the impact of incomplete revascularization in STEMI patients using the residual Synergy Between PCI with TAXUS and Cardiac Surgery score (rSS) to define completeness of revascularization.

Methods

This study examined associations between incomplete revascularization, determined by the rSS, and the combined outcome of cardiac death and myocardial infarction (MI). Patients were divided into groups: rSS = 0 (complete revascularization), rSS = 1-8 (incomplete revascularization with a low burden of residual disease), or rSS >8 (incomplete revascularization with a high burden of residual disease).

Results

The rSS score was calculated in 589 consecutive patients; 25% had an rSS of 0, 42% rSS 1-8, and 33% rSS >8. At median follow-up of 3.5 years, cardiac death and MI occurred in 5% of rSS = 0 patients, 15% rSS = 1-8, and 26% with rSS >8 (P < .001). The rSS was powerful independent predictor of cardiac death and MI (hazard ratio 5.05, CI 2.89-12.00, rSS >8 vs rSS 0, P < .001 and hazard ratio 2.96, CI 1.31-6.69, rSS = 1-8 vs rSS = 0, P = .009), respectively, and an independent predictor of mortality, MI, unplanned revascularization, and major adverse cardiovascular events.

Conclusions

In patients with STEMI, the rSS independently predicts cardiac death and MI. Patients with an rSS >8 had substantially higher rates of cardiac death or MI. The rSS can be used to define incomplete revascularization in STEMI and predict adverse outcomes.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Sources of funding: This study was completed without funding from industry or grants.


© 2018  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 205

P. 31-41 - Novembre 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension
  • William B. White, Fatima Jalil, Dorothy B. Wakefield, Richard F. Kaplan, Richard W. Bohannon, Charles B. Hall, Nicola Moscufo, Douglas Fellows, Charles R.G. Guttmann, Leslie Wolfson
| Articolo seguente Articolo seguente
  • Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction
  • Hong Xu, Jonas Faxén, Karolina Szummer, Marco Trevisan, Csaba P. Kovesdy, Tomas Jernberg, Juan Jesús Carrero

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.